Effect of the suppository base on progesterone delivery from the vagina.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Fertility and Sterility

• Publication date

  1983-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0015-0282(16)46938-4PMID 6832405
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Single luteal phase serum progesterone assay as an indicator of ovulation.

  1997cited by this paper
• Diagnosis of Luteal Phase Inadequacy

  1980cited by this paper
• Preparation of progesterone suppositories.

  1977cited by this paper
• Plasma levels of progesterone after vaginal, rectal, or intramuscular administration of progesterone.

  1971cited by this paper
• Disappearance rate on progesterone following simultaneous removal of the corpus luteum and the foeto-placental unit in women.

  1970cited by this paper

• Development and evaluation of innovative enteric-coated capsules for colon-specific delivery of hydrophilic biomaterials.

  2024cites this paper
• Vagina, a promising route for drug delivery

  2024cites this paper
• Potential Therapeutic Options and Perspectives for Alleviation of Endometrial Estrogen Dominance and Progesterone Resistance in Endometriosis

  2021cites this paper
• Gelatin and glycerine-based bioadhesive vaginal hydrogel.

  2020cites this paper
• Endometrial Histology and Safety on Non-Oral Routes of Hormone Therapy for Perimenopausal/Early Menopausal Women: Transdermal Estrogens and Vaginal Micronized Progesterone

  2019cites this paper
• Efficacy of four vaginal progesterones for luteal phase support in frozen‐thawed embryo transfer cycles: A randomized clinical trial

  2019cites this paper
• Using pressurised gyration to generate mucoadhesive progesterone-loaded fibres for drug delivery applications

  2018cites this paper
• Investigating progesterone and estrogen receptor crosstalk in breast cancer

  2017cites this paper
• Gelatin–PEG based metronidazole-loaded vaginal delivery systems: preparation, characterization and in vitro antimicrobial efficiency

  2014cites this paper
• Effect of vaginal administration of prostaglandin E2 and/or 17beta-estradiol on luteal function and histological characteristics of the cervix in cyclic pigs.

  2014cites this paper
• Progesterone for premenstrual syndrome.

  2012cites this paper
• The effect of intravaginal application of estradiol and progesterone on porcine embryo development.

  2008cites this paper
• Investigation of Product Quality Between Extemporaneously Compounded Progesterone Vaginal Suppositories and an Approved Progesterone Vaginal Gel

  2004cites this paper
• A randomised comparison of side effects and patient inconvenience of two vaginal progesterone formulations used for luteal support in in vitro fertilisation cycles.

  2003cites this paper
• Comparison between different routes of progesterone administration as luteal phase support in infertility treatments.

  2000cites this paper
• Pharmacokinetics of natural progesterone administered in the form of a vaginal tablet.

  1999cites this paper
• Transvaginal progesterone: evidence for a new functional 'portal system' flowing from the vagina to the uterus.

  1999cites this paper
• Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel‐releasing intrauterine device or natural progesterone

  1998cites this paper
• Plasma concentrations of progesterone are higher in the uterine artery than in the radial artery after vaginal administration of micronized progesterone in an oil-based solution to postmenopausal women.

  1998cites this paper
• Effects of Penetration Enhancers on the In‐vitro Percutaneous Absorption of Progesterone

  1997cites this paper
• Progesterone Support for Early Pregnancy

  1997cites this paper
• Pharmacokinetics and endometrial effects of the vaginal administration of micronized progesterone in an oil-based solution to postmenopausal women.

  1996cites this paper
• Further data favoring the hypothesis of the uterine first-pass effect of vaginally administered micronized progesterone.

  1996cites this paper
• Micronized progesterone: vaginal and oral uses.

  1995cites this paper
• Initial and steady-state pharmacokinetics of a vaginally administered formulation of progesterone.

  1995cites this paper
• Endometrial hyperplasia: efficacy of a new treatment with a vaginal cream containing natural micronized progesterone.

  1994cites this paper
• Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study.

  1994cites this paper
• A critical review of methodological issues and approaches to managing premenstrual syndrome

  1991cites this paper
• Progesterone administration by nasal spray.

  1991cites this paper
• The aetiology of premenstrual syndrome is with the progesterone receptors.

  1990cites this paper
• Double-blind controlled trial of progesterone substitution in threatened abortion.

  1987cites this paper
• Cyclic administration of an LHRH analogue and of progesterone in risk patients to oral contraceptives.

  1987cites this paper
• Premenstrual syndrome: a double blind placebo controlled study of treatment with progesterone vaginal suppositories

  1987cites this paper
• Comparison of serum progesterone levels in dogs after administration of progesterone by vaginal tablet and vaginal suppositories.

  1987cites this paper
• Serum progesterone levels following vaginal administration of progesterone during the luteal phase.

  1987cites this paper
• Bioavailability of progesterone with different modes of administration.

  1987cites this paper
• Progesterone for Premenstrual Syndrome

  1986cites this paper
• Bioavailability of nasally administered progesterone.

  1986cites this paper
• Progesterone Suppositories in Premenstrual Syndrome

  1985cites this paper
• Effectiveness of vaginal administration of progesterone

  1985cites this paper
• Evaluation of techniques for induction of ovulation in outpatients employing pulsatile gonadotropin releasing hormone.

  1984cites this paper